Literature DB >> 9498750

Requirement for Jak3 in mature T cells: its role in regulation of T cell homeostasis.

S J Sohn1, K A Forbush, N Nguyen, B Witthuhn, T Nosaka, J N Ihle, R M Perlmutter.   

Abstract

The tyrosine kinase Jak3 plays a key role in transducing signals from the IL-2, -4, -7, -9, and -15 receptors. Mice lacking Jak3 exhibit a profound, early block in both B and T cell development. To examine the mechanisms whereby Jak3 influences T cell function, we have reconstituted thymic development in Jak3-/- animals by introducing a Jak3 transgene in which expression was driven by the lck proximal promoter. Thymic reconstitution required Jak3 kinase activity, as catalytically inactive Jak3 did not restore early thymic development. Furthermore, the thymus-restricted expression pattern of the transgene allowed us to assess the requirement for Jak3 in peripheral T cells. In these mice, loss of Jak3 expression was associated with a failure to proliferate in response to antigen receptor crosslinking, the accumulation of T cells manifesting an activated cell surface phenotype, and an increased CD4/CD8 ratio among peripheral T cells, all of which are characteristics that were observed in Jak3-/- animals. Finally, we present data which suggest that peripheral T cells proliferate more rapidly in vivo and also undergo apoptosis more rapidly, upon loss of Jak3. Hence Jak3 exerts effects on mature peripheral T lymphocytes, as well as on thymocytes, resulting in the proper maintenance of circulating, quiescent cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9498750

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  Jak3 selectively regulates Bax and Bcl-2 expression to promote T-cell development.

Authors:  R Wen; D Wang; C McKay; K D Bunting; J C Marine; E F Vanin; G P Zambetti; S J Korsmeyer; J N Ihle; J L Cleveland
Journal:  Mol Cell Biol       Date:  2001-01       Impact factor: 4.272

2.  Activation of p38 mitogen-activated protein kinase in vivo selectively induces apoptosis of CD8(+) but not CD4(+) T cells.

Authors:  C Merritt; H Enslen; N Diehl; D Conze; R J Davis; M Rincón
Journal:  Mol Cell Biol       Date:  2000-02       Impact factor: 4.272

Review 3.  The common γ-chain cytokine receptor: tricks-and-treats for T cells.

Authors:  Adam T Waickman; Joo-Young Park; Jung-Hyun Park
Journal:  Cell Mol Life Sci       Date:  2015-10-14       Impact factor: 9.261

4.  Putative role for interleukin-7 in the maintenance of the recirculating naive CD4+ T-cell pool.

Authors:  L M Webb; B M Foxwell; M Feldmann
Journal:  Immunology       Date:  1999-11       Impact factor: 7.397

5.  Autocrine release of interleukin-9 promotes Jak3-dependent survival of ALK+ anaplastic large-cell lymphoma cells.

Authors:  Lin Qiu; Raymond Lai; Quan Lin; Esther Lau; David M Thomazy; Daniel Calame; Richard J Ford; Larry W Kwak; Robert A Kirken; Hesham M Amin
Journal:  Blood       Date:  2006-06-08       Impact factor: 22.113

6.  Jak3-independent trafficking of the common gamma chain receptor subunit: chaperone function of Jaks revisited.

Authors:  Sigrun R Hofmann; Albert Q Lam; Stephan Frank; Yong-Jie Zhou; Haydeé L Ramos; Yuka Kanno; Davide Agnello; Richard J Youle; John J O'Shea
Journal:  Mol Cell Biol       Date:  2004-06       Impact factor: 4.272

7.  Disruption of T cell homeostasis in mice expressing a T cell-specific dominant negative transforming growth factor beta II receptor.

Authors:  P J Lucas; S J Kim; S J Melby; R E Gress
Journal:  J Exp Med       Date:  2000-04-03       Impact factor: 14.307

Review 8.  Protein Arginine Methyltransferase 5 in T Lymphocyte Biology.

Authors:  Shouvonik Sengupta; Austin Kennemer; Kristin Patrick; Philip Tsichlis; Mireia Guerau-de-Arellano
Journal:  Trends Immunol       Date:  2020-09-02       Impact factor: 19.709

9.  Baseline JAK phosphorylation profile of peripheral blood leukocytes, studied by whole blood phosphospecific flow cytometry, is associated with 1-year treatment response in early rheumatoid arthritis.

Authors:  Krista Kuuliala; Antti Kuuliala; Riitta Koivuniemi; Hannu Kautiainen; Heikki Repo; Marjatta Leirisalo-Repo
Journal:  Arthritis Res Ther       Date:  2017-04-11       Impact factor: 5.156

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.